KIT and acute myeloid leukemia: Previously, it has been shown that primary AML progenitor cells, characterized by the co-expression of CD34 and CD117 express the somatostatin receptor (SSTR) subtype 2 and that the expression of the SSTR2 receptor was not restricted to the immature CD34+CD117+ compartment, but also detected on more differentiated AML blasts.